Six Years of Exercise (or Lack of Exercise) Could Change Your Risk of Heart Failure
Posted by: Alexander Ward on: May 21, 2018 | Print This Page
Review finds that consistently participating in recommended amount of physical activity in middle age can reduce heart failure risk by as much as 31 percent
The same analysis found that as little as six years without physical activity in middle age was linked to an increased risk of the disorder.
“Our findings suggest that consistently participating in the recommended 150 minutes of moderate to vigorous activity each week … in middle age may be enough to reduce your heart failure risk by 31 percent.”Chiadi NdumeleProfessor, School of Medicine
Unlike a heart attack, in which heart muscle dies, heart failure is marked by a long-term, chronic inability of the heart to pump enough blood, or pump it hard enough, to bring needed oxygen to the body. The condition affects an estimated 5 million to 6 million Americans and is the leading cause of hospitalizations in those over 65, with risk factors including high blood pressure, high cholesterol, diabetes, smoking, and a family history.
“In everyday terms our findings suggest that consistently participating in the recommended 150 minutes of moderate to vigorous activity each week, such as brisk walking or biking, in middle age may be enough to reduce your heart failure risk by 31 percent,” says Chiadi Ndumele, professor at the Johns Hopkins University School of Medicine and the senior author of a report on the study. “Additionally, going from no exercise to recommended activity levels over six years in middle age may reduce heart failure risk by 23 percent.”
The researchers caution that their study, described in the May 15 edition of the journal Circulation, was observational, meaning the results can’t and don’t show a direct cause-and-effect link between exercise and heart failure. But they say the trends observed in data gathered on middle-aged adults suggest that it may never be too late to reduce the risk of heart failure with moderate exercise.
“The population of people with heart failure is growing because people are living longer and surviving heart attacks and other forms of heart disease,” says Roberta Florido, cardiology fellow at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. “Unlike other heart disease risk factors like high blood pressure or high cholesterol, we don’t have specifically effective drugs to prevent heart failure, so we need to identify and verify effective strategies for prevention and emphasize these to the public.”
There are drugs used to treat heart failure, such as beta blockers and ACE inhibitors, but they are essentially “secondary” prevention drugs, working to reduce the heart’s workload after dysfunction is already there.
Several studies, Florido says, suggest that in general, people who are more physically active have lower risks of heart failure than those who are less active. But little was known about the impact of changes in exercise levels over time on heart failure risk. For example, if you are sedentary most of your life but then start exercising in middle age, does that decrease your risk of heart failure? Or, if you are active much of your life but then stop being active at middle age, will that increase your risk?
To address those questions, the researchers used data already gathered from 11,351 participants in the federally funded, long-term Atherosclerosis Risk in Communities (ARIC) study, recruited from 1987 to 1989 in Forsyth County, North Carolina; Jackson, Mississippi; greater Minneapolis, Minnesota; and Washington County, Maryland.
The participants’ average age was 60, 57 percent were women, and most were either white or African-American.
Participants were monitored annually for an average of 19 years for cardiovascular disease events such as heart attack, stroke, and heart failure using telephone interviews, hospital records, and death certificates. Over the course of the study there were 1,693 hospitalizations and 57 deaths due to heart failure.
In addition to those measures, at the first and third ARIC study visits (six years apart), each participant filled out a questionnaire that asked them to evaluate their physical activity levels, which were then categorized as poor, intermediate, or “recommended,” in alignment with guidelines issued by the American Heart Association.
The “recommended” amount is at least 75 minutes per week of vigorous intensity or at least 150 minutes per week of moderate intensity exercise. According to the American Heart Association, fewer than 50 percent of Americans overall get recommended activity levels.
For the purposes of the study, one to 74 minutes per week of vigorous intensity or one to 149 minutes per week of moderate exercise per week counted as intermediate level activity. And physical activity qualified as “poor” if there was no exercise at all.
After the third visit, 42 percent of participants (4,733 people) said they performed recommended levels of exercise; 23 percent (2,594 people) said they performed intermediate levels; and 35 percent (4,024 people) said they had poor levels of activity. From the first to the third visit over about six years, 24 percent of participants increased their physical activity, 22 percent decreased it and 54 percent stayed in the same category.
Those with recommended activity levels at both the first and third visits showed the highest associated heart failure risk decrease, at 31 percent compared with those with consistently poor activity levels.
Heart failure risk decreased by about 12 percent in the 2,702 participants who increased their physical activity category from poor to intermediate or recommended, or from intermediate to recommended, compared with those with consistently poor or intermediate activity ratings.
Conversely, heart failure risk increased by 18 percent in the 2,530 participants who reported decreased physical activity from visit one to visit three, compared with those with consistently recommended or intermediate activity levels.
Other authors on the study include Lucia Kwak, Mariana Lazo, Gary Gerstenblith, Roger Blumenthal, Elizabeth Selvin, and Josef Coresh of Johns Hopkins; Vijay Nambi and Christie Ballantyne of Baylor College of Medicine; Haitham Ahmed of Cleveland Clinic; Sheila Hegde of Brigham and Women’s Hospital; and Aaron Folsom of University of Minnesota.
The research was funded by a Robert E. Meyerhoff Professorship; a Robert Wood Johnson Amos Medical Faculty Development Award; a JHU Catalyst Award; and grants from the National Heart, Lung, and Blood Institute (K23HL12247) and the National Institute of Diabetes and Digestive and Kidney Diseases (K24DK106414).